IGC Pharma Overview
IGC Pharma Discounted Cash Flow
DCF Analysis for IGC.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.11
Current Fair Value
$-0.11
↓ 138.6% Downside
Overvalued by 138.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison